focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

JCC Subsidiary Agreement

1 Jun 2006 07:01

Marchpole Holdings PLC01 June 2006 Marchpole Holdings plc ("Marchpole" or "the Group") Subsidiary Jean Charles de Castelbajac Shop in shop agreement with Galleries Lafayette Marchpole Holdings plc, the fast growing fashion brand management group, ispleased to announce that its wholly owned subsidiary Jean Charles de Castelbajac("JCC") has signed a contract with Galleries Lafayette to open a 'shop-in-shop'in the landmark Galleries Lafayette department store on Boulevard Hausman inParis. The agreement will see clothes and accessories from the JCC range being sold in350 sq feet of store space in the iconic Parisian store from July 2006. Thisagreement follows JCC's major new licence agreement with OKAIDI Group, announcedin May 2006, and is another significant step in the development of the brand,following Marchpole's acquisition of JCC in 2004. In addition to enhancing thereputation of the JCC brand, the opening will broaden the reach of the brand andincrease the turnover of JCC. Group Galleries Lafayette, one of France's largest retailers, has 61 "GalleriesLafayette" stores throughout France. In 2005, the Group made over €4,943.6million in sales. The Group's flagship Boulevard Hausman department storehouses a wide range of international luxury brands. Michael Morris, executive Deputy Chairman of Marchpole, commented: "I'mdelighted with this latest development for Jean Charles de Castelbajac whichwill increase the brand's presence and reputation in a key target market. Theagreement underlines Marchpole's commitment to growing our business andextending the reach of our brands." - ends - For further information: Emma Kent, Bell Pottinger Corporate & Financial: 0207 861 3232 John Harrison, Finance Director, Marchpole: 0207 908 7777 Notes to Editors - Marchpole Holdings plc ("Marchpole") is an international brand management group that designs, produces and sells clothing and accessories for seven world class fashion labels. It operates in all of the world's main markets - UK, mainland Europe, Asia and the USA - Its respected brands include YSL, Boateng, Emmanuel Ungaro, Ungaro, Jean-Charles de Castelbajac ("JCC"), Jean-Charles de Castelbajac / Rossignol and Jean-Charles de Castelbajac / Okaidi - Incorporated in 1973, Marchpole listed on the London Stock Exchange in 1997 and has the ticker symbol MPH - Marchpole is renowned for its integrated approach to brand management, taking a brand from concept to design studio to the customer interface. It is not a clothing manufacturer - The Group has grown considerably in the past 3 years, from a licensee with one core license (YSL menswear) - to today's international business that manages its brands across a multitude of clothing lines and accessories - Marchpole's most recent acquisition (March 2006) of Moda America - the US licensee for leading designer Emanuel Ungaro - brings further growth opportunities in the UK and America and strengthens the company's relationship with Ungaro - The acquisition also allows the company to launch the Ungaro brand, already established by Marchpole in Europe and Asia, into the US, Canada and South America. The acquisition also allows the company to re-launch JCC into America with effect from autumn/winter 2006 - Marchpole will launch the diffusion Ungaro Homme collection in the UK from Spring/Summer 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th May 20177:00 amRNSInitiation of BPS-804 Phase 2b study
28th Apr 20173:37 pmRNSHolding(s) in Company
28th Apr 201712:53 pmRNSHolding(s) in Company
28th Apr 201710:05 amRNSHolding(s) in Company
26th Apr 20177:00 amRNSConversion of loan note and issue of equity
24th Apr 20176:07 pmRNSHolding(s) in Company
5th Apr 20177:00 amRNSGrant of Options and Awards
3rd Apr 20177:00 amRNSResults of Placing
31st Mar 20175:54 pmRNSResults of Placing
29th Mar 201712:30 pmRNSProposed Placing
15th Mar 20177:00 amRNSPosting of Annual Report and Notice of AGM
7th Mar 20177:00 amRNSPositive recommendation for BGS-649 Phase 2b trial
27th Feb 20177:00 amRNSPreliminary Results
20th Feb 20177:00 amRNSEMA Adaptive Pathways programme accepts BPS-804
23rd Jan 20177:05 amRNSPresentation at Shares Spotlight Evening
23rd Jan 20177:00 amRNSThree abstracts accepted for ATS Meeting
12th Jan 20177:01 amRNSDirectorate update
5th Jan 201712:00 pmRNSMereo BioPharma to Present at Biotech Showcase
12th Dec 20167:00 amRNSBusiness Update
7th Nov 20167:10 amRNSAppointment of Chief Financial Officer
3rd Nov 20167:00 amRNSPositive Phase 1 interaction study with BCT-197
5th Oct 20167:00 amRNSDirectorate Change
16th Sep 20167:00 amRNSHalf-year Report
9th Aug 20164:04 pmRNSNotice of Results
18th Jul 20161:25 pmRNSResult of AGM
30th Jun 20167:00 amRNSBPS-804 granted EU orphan drug status
24th Jun 201612:47 pmRNSNotice of AGM
9th Jun 20161:17 pmRNSDirector/PDMR Shareholding
9th Jun 20168:01 amRNSFirst Day of Dealings on AIM
10th Nov 20086:21 pmRNSFurther re financial position
4th Nov 20083:01 pmRNSStatement re suspension
4th Nov 20083:00 pmRNSSuspension
23rd Oct 20084:35 pmRNSHolding(s) in Company
23rd Oct 20082:25 pmRNSAGM Statement
2nd Oct 20083:14 pmRNSHolding(s) in Company
23rd Sep 200810:02 amRNSNotice of AGM
1st Sep 200810:06 amRNSHolding(s) in Company
29th Aug 20083:20 pmRNSResult of GM and Interim Mana
26th Aug 200810:13 amRNSHolding(s) in Company
19th Aug 20082:22 pmRNSHolding(s) in Company
14th Aug 20084:23 pmRNSHolding(s) in Company
13th Aug 200811:00 amRNSDirectorate Change
8th Aug 200811:14 amRNSHolding(s) in Company
8th Aug 200811:03 amRNSHolding(s) in Company
7th Aug 20084:46 pmRNSHolding(s) in Company
6th Aug 20084:41 pmRNSSecond Price Monitoring Extn
6th Aug 20084:36 pmRNSPrice Monitoring Extension
6th Aug 20083:17 pmRNSDirector/PDMR Shareholding
6th Aug 20087:08 amRNSFundraising and New Board App
6th Aug 20087:05 amRNSNew Joint Venture

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.